Trade union representative: STELLANTIS told us that the output of Italy in 2025 will be similar to this year, about 500,000 vehicles.The European Central Bank opened the door for further interest rate cuts. On Thursday, the European Central Bank cut interest rates for the fourth time this year and opened the door for further interest rate cuts in the future, because inflation is close to its target and the economy is still weak. The European Central Bank lowered the deposit interest rate from 3.25% to 3.0%, and cancelled the statement that the interest rate remained "sufficiently restrictive", suggesting that it was possible to cut interest rates further. The European Central Bank said: "The financial environment is easing, because the recent interest rate cuts by the European Central Bank have gradually reduced the new borrowing costs of enterprises and households." "But the financial environment is still very tight, because monetary policy is still restrictive, and past interest rate hikes are still being transmitted to outstanding stock credit."ECB: The appropriate monetary policy stance will be determined by data dependence and successive meetings. Inflation prospect, core inflation and its transmission will determine the interest rate path.
The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)Wal-Mart Financial Technology Company is valued at $2.5 billion, and retailers inject a lot of cash.During the "slimming" of the brokerage business department, more than 100 companies were cancelled during the year, and the competition turned to differentiated services. The brokerage business of brokerage companies is welcoming a new round of changes. In the past few days, a number of brokers have announced the cancellation of their relevant business departments. According to the reporter's incomplete statistics, in the past two weeks, many brokers such as Nanjing Securities, Guosen Securities and Pacific Securities announced that they would "streamline" their business departments. Looking at it for a long time, more than 35 brokers have issued announcements during the year, "downsizing" hundreds of business departments. Insiders pointed out that the traditional offline outlet business development model has increasingly shown drawbacks and high cost pressure; At the same time, more and more customers rely on online transactions and mobile terminal transactions, so it is imperative to "streamline" the business department to reduce costs and increase efficiency. Future competition depends more on differentiated financial management and trading services. (Shell Finance)
The European Central Bank gave up the idea of keeping interest rates "restrictive".South Korea's finance ministers and Japan's finance ministers held an online meeting, and the two sides reiterated the importance of the partnership between the two countries.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14